Prostate Cancer Clinical Trials in Nashville

Showing 161-180 of 187 trials

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00471718

RATIONALE: Drugs used in chemotherapy, such as ABT-751, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I/II trial is studying the side effects and best dose of ABT-751 and to see how well it works in treating patients with metastatic prostate cancer that did not respond to hormone therapy.

Prostate Cancer

Vanderbilt-Ingram Cancer Center27 participantsStarted Jan 2004

Nashville, Tennessee, United States

COMPLETEDPHASE3< 1 mile

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

NCT00657904

The purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in subjects with histologically or cytologically confirmed non-metastatic adenocarcinoma of the prostate gland.

Non-metastatic Prostate Cancer

AstraZeneca3,618 participantsStarted Aug 1995

Birmingham, Alabama, United States • Mobile, Alabama, United States • Scottsdale, Arizona, United States +82 more locations

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

Prostate Cancer Trials in Other Cities

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

3-AP in Treating Patients With Advanced Prostate Cancer

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008

Other Conditions in Nashville